Hyperbaric Oxygen Shows Promise for Autism Spectrum Disorders in New Review

Autism spectrum disorders (ASD) represent a complex group of neurodevelopmental conditions involving intricate interactions between environmental, genetic, and neurobiological factors. As diagnosis rates increase and understanding of ASD etiology expands, researchers are actively seeking more effective treatment approaches beyond traditional interventions.

This comprehensive review examined hyperbaric oxygen therapy (HBOT) as a potential complementary treatment for ASD. The therapy's proposed mechanisms include anti-inflammatory effects, modulation of neuroplasticity, and potential reduction of oxidative stress levels - all factors that may contribute to ASD symptoms.

Current research indicates that HBOT may improve specific behavioral and cognitive aspects in individuals with ASD, particularly speech development, communication skills, and psychosocial functioning. These improvements could significantly impact quality of life for both patients and families dealing with ASD challenges.

However, the review noted that research results remain inconsistent, partly due to potential adverse effects associated with HBOT treatment. These include barotrauma (pressure-related injuries) and oxygen toxicity, which must be carefully weighed against potential benefits. The heterogeneous nature of ASD itself may also contribute to variable treatment responses across different individuals and studies.